| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 1.000 | None | 0.979 | 78 | 0 | 1989 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 0.962 | 5 | 0 | 1992 | 2019 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.090 | None | 1.000 | 3 | 0 | 2002 | 2018 | ||||||||
|
serine protease 8 | 0.641 | 0.500 | 0.10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2008 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.100 | None | 0.909 | 2 | 0 | 1998 | 2019 | ||||||||
|
arylsulfatase B | 0.595 | 0.692 | 7.0E-09 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
sodium channel epithelial 1 subunit beta | 0.628 | 0.577 | 5.8E-08 |
|
disease | 0.600 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
disease | 0.090 | None | 1.000 | 2 | 0 | 1990 | 2016 | ||||||||
|
sodium channel epithelial 1 subunit gamma | 0.633 | 0.577 | 0.48 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2006 | 2019 | ||||||||
|
toll like receptor 5 | 0.518 | 0.885 | 2.5E-13 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2008 | 2013 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 1992 | 2008 | ||||||||
|
SLC9A3 regulator 1 | 0.547 | 0.577 | 8.8E-05 |
|
disease | 0.050 | None | 1.000 | 2 | 0 | 2002 | 2015 | ||||||||
|
C-C motif chemokine ligand 17 | 0.518 | 0.808 | 1.4E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
C-C motif chemokine ligand 3 | 0.460 | 0.885 | 0.35 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
phospholipase A2 group IIA | 0.488 | 0.808 | 9.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
FXYD domain containing ion transport regulator 5 | 0.615 | 0.577 | 2.1E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
sodium channel epithelial 1 subunit alpha | 0.601 | 0.577 | 1.1E-11 |
|
disease | 0.390 | None | 0.909 | 1 | 0 | 2004 | 2017 | ||||||||
|
triggering receptor expressed on myeloid cells 1 | 0.515 | 0.808 | 6.3E-03 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
protein kinase C epsilon | 0.597 | 0.692 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2004 | 2018 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 2 | 0.456 | 0.846 | 3.5E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
surfactant protein B | 0.575 | 0.654 | 2.6E-04 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2018 |